The latest closing stock price for Context Therapeutics as of November 08, 2024 is 1.95.
An investor who bought $1,000 worth of Context Therapeutics stock at the IPO in 2021 would have $-618 today, roughly -1 times their original investment - a -27.42% compound annual growth rate over 3 years.
The all-time high Context Therapeutics stock closing price was 7.45 on October 25, 2021.
The Context Therapeutics 52-week high stock price is 2.75, which is 41% above the current share price.
The Context Therapeutics 52-week low stock price is 0.77, which is 60.5% below the current share price.
The average Context Therapeutics stock price for the last 52 weeks is 1.64.
An investor who bought $1,000 worth of Context Therapeutics stock at the IPO in 2021 would have $-618 today, roughly -1 times their original investment - a -27.42% compound annual growth rate over 3 years.
The all-time high Context Therapeutics stock closing price was 7.45 on October 25, 2021.
The Context Therapeutics 52-week high stock price is 2.75, which is 41% above the current share price.
The Context Therapeutics 52-week low stock price is 0.77, which is 60.5% below the current share price.
The average Context Therapeutics stock price for the last 52 weeks is 1.64.